(NP (NP (NP Demonstration/NN) (PP of/IN (NP (NP a/DT (ADJP 1,25-dihydroxyvitamin/NN D3-responsive/JJ) protein/NN) (PP in/IN (NP human/JJ lymphocytes/NNS)))) :/:) (NP (NP-COOD (NP immunologic/JJ crossreactivity/NN) and/CC (NP inverse/JJ regulation/NN)) (PP with/IN (NP the/DT vitamin/NN D/NN receptor/NN))) ./.)
(S (S-ADV (NP-SBJ *-25/-NONE-) (VP Using/VBG (NP (NP Western/NN blot/NN analysis/NN) (PP with/IN (NP (NP a/DT monoclonal/JJ antibody/NN) (VP recognizing/VBG (NP (NP a/DT 17-amino/NN acid/NN epitope/NN) (PP of/IN (NP the/DT (NP (NP 1,25-dihydroxyvitamin/NN D3/NN) (PRN -LCB-/-LRB- (NP 1,25-LRB-OH-RRB-2D3/NN) -RCB-/-RRB-)) receptor/NN))))))))) ,/, (NP-SBJ-25 we/PRP) (VP have/VBP (VP detected/VBN (NP two/CD crossreacting/VBG proteins/NNS) (PP in/IN (NP activated/VBN normal/JJ human/JJ lymphocytes/NNS)))) ./.)
(S (NP-SBJ-26 (NP (NP The/DT smaller/JJR) (PP of/IN (NP the/DT two/CD proteins/NNS))) (PRN -LRB-/-LRB- (NP 50/CD kDa/NN) -RRB-/-RRB-)) (VP-COOD (VP was/VBD (ADJP-PRD indistinguishable/JJ (PP from/IN (NP the/DT classical/JJ 1,25-LRB-OH-RRB-2D3/NN receptor/NN)))) and/CC ,/, (VP (S-ADV (NP-SBJ *-27/-NONE-) (ADJP-PRD similar/JJ (PP to/TO (NP the/DT classical/JJ 1,25-LRB-OH-RRB-2D3/NN receptor/NN)) ,/,)) was/VBD (VP upregulated/VBN (NP-27 *-26/-NONE-) (PP in/IN (NP a/DT dose-dependent/JJ fashion/NN)) (PP by/IN (NP-LGS 1,25-LRB-OH-RRB-2D3/NN))))) ./.)
(S (NP-SBJ-28 The/DT larger/JJR crossreacting/VBG protein/NN) (VP-COOD (VP exhibited/VBD (NP (NP an/DT electrophoretic/JJ mobility/NN) (PP of/IN (NP 80/CD kDa/NN)))) ,/, (VP was/VBD (VP localized/JJ (NP *-28/-NONE-) (PP in/IN (NP the/DT cell/NN cytosol/NN)))) ,/, and/CC (VP appeared/VBD (S (NP-SBJ *-28/-NONE-) (VP to/TO (VP be/VB (ADJP-PRD specific/JJ (PP for/IN (NP activated/VBN lymphocytes/NNS))) (SBAR since/IN (S (NP-SBJ-29 it/PRP) (VP was/VBD not/RB (VP detected/VBN (NP *-29/-NONE-) (PP in/IN (NP (NP several/JJ other/JJ human/JJ cells/NNS) (PP including/VBG (NP monocytes/NNS))))))))))))) ./.)
(S (S (ADVP More/RBR strikingly/RB) ,/, (NP-SBJ-30 the/DT 80-kDa/JJ protein/NN) (VP was/VBD (VP downregulated/VBN (NP *-30/-NONE-) (PP in/IN (NP a/DT dose-dependent/JJ fashion/NN)) (PP by/IN (NP-LGS 1,25-LRB-OH-RRB-2D3/NN)))) ;/:) (S (NP-SBJ this/DT effect/NN) (VP was/VBD (ADJP-PRD-COOD (ADJP independent/JJ (PP of/IN (NP (NP the/DT mode/NN) (PP of/IN (NP lymphocyte/NN activation/NN))))) and/CC (ADJP specific/JJ (PP for/IN (NP (NP the/DT 1,25-LRB-OH-RRB-2D3/NN metabolite/NN) (PP of/IN (NP vitamin/NN D3/NN))))))) ./.))
(S (ADVP However/RB) ,/, (NP-SBJ (NP two/CD potent/JJ immunosuppressive/JJ agents/NNS) ,/, (NP-COOD (NP glucocorticoids/NNS) and/CC (NP cyclosporin/NN A/DT)) ,/,) (ADVP also/RB) (VP inhibited/VBD (NP the/DT 80-kDa/JJ protein/NN)) ./.)
